Trimetazidine Dihydrochloride IP 60 mg , Modified Release Tablet
10x10 tablet
Product Description
Description
Each Film Coated Modified Release Tablet Contains: Trimetazidine Dihydrochloride IP 60 mg
Doses
As Directed by Physician
Indication
Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Name
Comapny Name
Phone Number
Email Id
City / State
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
Youre Done!
We have received your requirements and will reply shortly with the best price.